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of tools and resources (e.g. scripting-language and version 
dependencies). For metabolomics to achieve its full poten-
tial in both the basic and applied sciences the accessibil-
ity, reporting, reproducibility and overall harmonisation of 
such computational tools and resources must be improved 
significantly. Only then can there be confidence that results 
obtained in one laboratory can be reproduced in another 
laboratory elsewhere across the globe. The development 
of standardised and reproducible computational workflows 
provides one route to achieving closer harmonisation. This 
is a logical evolution following the work of the Metabo-
lomics Standards Initiative where one working group 
aimed to establish minimal reporting requirements for data 
processing (Goodacre et al. 2007).
Galaxy is a widely used workflow platform that has 
helped to transform genomics research by increasing the 
accessibility of powerful data processing and analysis tools 
to non-bioinformaticians; i.e., to bench biologists (See 
“How to Build Bioinformatic Pipelines Using Galaxy” The 
1 Introduction
Over the past decade, metabolomics has transformed into 
a valuable scientific discipline, conducting comprehen-
sive and (semi-)quantitative investigations of metabolism. 
Consequently, metabolomics is increasingly used across a 
wide range of research fields from basic biology to applied 
disciplines such as medicine, toxicology, environment and 
agriculture. Its expansion has been accompanied by a sig-
nificant increase in the number of computational tools 
available to process and analyse metabolomics data. Such 
tools can provide automated and standardised operational 
pipelines for data pre-processing (e.g. chromatographic 
deconvolution or normalisation of data), univariate and 
multivariate statistical analysis, metabolite annotation 
and metabolic network modeling including deep learning 
strategies to detect new biological processes. Computa-
tional workflows are often complex and include a variety 
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Scientist, August 1st, 2016).1 Two Galaxy workflows have 
recently been reported for metabolomics (Davidson et  al. 
2016; Giacomoni et  al. 2015), representing a significant 
step towards harmonised metabolomics workflows. Build-
ing upon this, we have formed a consortium of United 
Kingdom laboratories with a mission to continue these 
efforts and to create and maintain standardised Galaxy 
workflows to be used by the metabolomics community. We 
also seek to coordinate our efforts with international com-
munities working on Galaxy-based metabolomics tools and 
environments, such as Workflow4Metabolomics in France 
(Giacomoni et al. 2015).
Our UK consortium has worked in collaboration with 
ELIXIR–UK and the Metabolomics Society to jointly con-
duct a community survey to:
1. Gauge the current knowledge of workflows in the inter-
national metabolomics community, in particular Gal-
axy workflows;
2. Determine what computational tools are currently 
being used and hence which are needed to be added to 
the Galaxy toolshed.
Here we report the results of the computational work-
flow questionnaire, from which we conclude that there is 
community wide support for the development of stand-
ardised and reproducible workflows for the growing inter-
national metabolomics community. By sharing the full 
results, we hope that others will conduct additional analy-
ses and be able to derive further interesting conclusions, 
which will collectively help to drive more open and trans-
parent approaches for data analysis and software develop-
ment in metabolomics.
2  Results questionnaire
We assembled a questionnaire comprised of 59 questions 
that asked for basic information about the respondent and 
their metabolomics experience as well as which software 
and hardware they used for their research. The question-
naire was conducted online using Survey Monkey (https://
www.surveymonkey.com), and was open for about 12 
weeks (from 16th November 2015 to 8th February 2016). 
It was promoted through multiple channels, including 
MetaboNews (http://www.metabonews.ca), websites (e.g. 
https://wiki.galaxyproject.org/GalaxyUpdates), metabo-
lomics mailing lists, Twitter and metabolomics-related 
1 “How to Build Bioinformatic Pipelines Using Galaxy | The Sci-
entist ...” 2016. 18 Aug. 2016 http://www.the-scientist.com/?articles.
view/articleNo/46670/title/How-to-Build-Bioinformatic-Pipelines-
Using-Galaxy/.
meetings and workshops. The majority of questions were 
multiple choice and respondents were able to select mul-
tiple answers for many of the questions (i.e. select all that 
apply). Respondents were guided to only answer ques-
tions related to their specific expertise, e.g. respondents 
who only use LC–MS were excluded from the subsequent 
questions about NMR spectroscopy. Here we summarise 
the most important findings. The complete set of responses 
(excluding personal identifiers) are available in full as 
electronic supplementary material (Supplementary Infor-
mation 1–3 (SI1–3) and http://metabolomicssociety.org/
computational-tools-and-workflows-questionnaire).
In total, 71 people responded to the survey, from which 
ca. 80% were academic scientists. No respondents were 
excluded from the survey. The respondents were at dif-
ferent stages of their academic career (such as PhD, post-
doctoral researchers, scientific staff and principal inves-
tigators), which is also represented by their degree of 
experience in the field (2–4 years = 32%; 4–6 years = 20%; 
>8 years = 20%;). The majority (61%) of the respondent’s 
daily activities consisted of a combination of “wet” and 
“dry” laboratory work. In terms of geographical spread, 
the highest percentage of respondents were from France 
(32%) followed by Germany (12%), the UK (12%) and the 
USA (9%). Respondents used a large variety of analytical 
techniques (e.g. NMR spectroscopy and mass spectrom-
etry) and applied metabolomics in different areas of sci-
ence. Overall, the questionnaire included a relatively wide 
and diverse distribution of metabolomics practitioners (See 
SI 2, and [Metabolomics Society website, url not avail-
able yet]), suggesting that it fairly represents the commu-
nity wide practices, though with a bias towards academic 
disciplines.
Respondents were then asked general questions 
regarding their use of workflows, if any, and other com-
putational needs and resources as well as training needs 
in using workflows. Regarding bottlenecks in existing 
workflows, they stated that “data processing and statisti-
cal analyses” (68%) are the most time consuming steps 
in their workflows, followed by “Data curation” (45%). 
Also, approximately half of all respondents do not have 
access to dedicated bioinformatics support (51%). These 
findings reveal the need to develop accessible and repro-
ducible tools and workflows that focus specifically on 
removing these main bottlenecks, without the need for 
skilled bioinformaticians (who are in short supply and 
high demand). In terms of their current knowledge of 
workflows, respondents are more aware of the Galaxy 
platform than any other workflow environment (59%). 
While the active use of (any) workflow platforms in 
metabolomics is still low (25% had no knowledge or 
experience), responders are using the Galaxy platform 
more than any other (Taverna—4%, KNIME—3% and 
Computational tools and workflows in metabolomics: An international survey highlights the…
1 3
Page 3 of 5 12
Galaxy—13%). Approximately 99% of respondents 
stated that they would (51%) or possibly would (48%) 
use Galaxy, if their most used metabolomics tools were 
incorporated into that platform. Furthermore, a relative 
high percentage of respondents anticipate that their data 
would require access constraints (e.g. password protec-
tion or anonymisation) in any of the workflows developed 
(63%). In terms of education, respondents would (68%) 
or possibly would (31%) like to receive training in the 
operation of Galaxy metabolomics workflows. Respond-
ents were also positive about receiving training in the 
development of Galaxy metabolomics workflows (59%—
would and 32%—possibly would). In view of these 
encouraging findings, it is clear that bioinformatics in our 
community should build on the existing support of Gal-
axy through the development of Galaxy-specific tools as 
well as training courses for applied scientists, and hack-
athons for those wishing to further develop Galaxy tools 
and workflows.
Additional questions were asked regarding analyti-
cal and computational tools used to process, analyse and 
annotate metabolomics data. Approximately 74% of the 
responders typically conduct about five or more studies 
per year, and conduct either untargeted (87%) and/or tar-
geted (52%) approaches. By far the majority of respond-
ents utilised LC–MS (83%) methods in their research, 
followed by GC–MS (30%), NMR (26%), DIMS (16%), 
imaging mass spectrometry (6%, see (Palmer et  al. 
2016) for a specific survey on Imaging Mass Spectrom-
etry), MALDI–MS (4%) and CE–MS (3%). It is worth 
noting that some of the respondents use multiple tech-
nologies across their studies. Encouragingly, a wide dis-
tribution of open data formats are used across the differ-
ent MS (e.g. mzXML 70% and mzML 41%) and NMR 
platforms. Although mzML (Martens et  al. 2011) and 
nmrML (http://www.nmrml.org) are the community rec-
ommended data standards, it is not clear from the survey 
that such acceptance and harmonisation exists. Consid-
ering that mzXML (Lin et  al. 2005) is the precursor to 
mzML, adoption at this level is very encouraging. How-
ever, more community efforts are required to further 
reinforce the benefits of using established data standards 
(Salek et al. 2015; Rocca-Serra et al. 2016). The major-
ity of respondents (91%) produce datasets that comprise 
of 50–500 samples. A small percentage (7%) produce 
datasets that consist of >1000 samples per study. The file 
sizes across those studies vary with the majority of those 
(86%) working with file size ≤250 Megabytes per sample. 
However, 14% were using files sizes >1 Gigabyte. The 
backend specifications of a workflow platform, such as 
Galaxy, should therefore be sufficient for uploading, ana-
lysing and storing what can potentially be a high num-
ber of large files. It is notable and arguably encouraging 
that ca. 41% of respondents have used open data reposi-
tories (e.g. MetaboLights or Metabolomics Workbench) 
in their research (Haug et al. 2012; Sud et al. 2016). This 
value is significantly larger than when the same ques-
tion was asked in an international survey in 2014 (7%) 
(Weber et al. 2015). While this indicates the community 
is gradually recognising the value of such repositories (or 
perhaps are responding to the demands of journal edi-
tors or funding bodies), more needs to be done to fur-
ther encourage the community to use repositories within 
standardised workflows.
The international survey, for the first time, also revealed 
the relative uses of multiple data processing software pack-
ages and tools (See SI2).
•	 Respondents that conduct LC–MS primarily used open 
source software (84%) and/or commercial software 
bundled with the instrument (65%); the open source 
software is strongly dominated by XCMS (70%), with 
mzMine and mzMine2 the next most utilised tools 
(26%).
•	 Respondents that conduct GC–MS are almost equally 
split between commercial software bundled with the 
instrument (76%) and open source software (67%). The 
commercial software is dominated by Agilent Chemsta-
tion (45%) while the non-commercial software is domi-
nated by AMDIS (50%) and XCMS (40%).
•	 Respondents that conduct NMR spectroscopy primar-
ily used commercial software bundled with the instru-
ment (ca. 78%) and/or secondarily third-party commer-
cial software (ca. 50%); the commercial software that is 
primarily utilised is Bruker’s TopSpin (56%) while the 
non-commercial software that is primarily utilised are 
NMRlab/MetaboLab (17%) and rNMR (17%).
•	 Respondents that conduct DIMS primarily used open 
source software (55%) although there are also a large 
number of responders using commercial software (bun-
dled with the instrument 36% and/or third party 18%); 
the open source software is again dominated by XCMS 
(50%).
Based on these findings we believe that data-process-
ing is a relatively well established process within MS and 
NMR-based metabolomics. While XCMS is the dominant 
solution to process MS data (i.e. LC–MS, GC–MS and 
DIMS), NMR data processing is mainly conducted using 
commercial software. Unfortunately, commercial software 
is largely unsuitable for implementing into freely available 
Galaxy workflows due to license issues. However, for both 
MS and NMR metabolomics methods, open-source data 
processing tools are available within Galaxy (Davidson 
et al. 2016; Giacomoni et al. 2015).
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Further questions were asked about the types of data 
analyses that are currently being conducted in the com-
munity. The majority of respondents performed statisti-
cal analysis in their research (85%), and used a combina-
tion of univariate (e.g. Student t-test 91%; ANOVA 89%; 
Mann–Whitney U test 54%; Benjamini–Hochberg false 
discovery rate correction 50%; Kruskal Wallis 44%) and 
multivariate (e.g. PCA 96%; PLS-DA 73%; O-PLS 39%; 
HCA 39%; Random Forest 27%) methods (See SI2). Addi-
tionally, the majority of the respondents performed meta-
bolic network or enrichment analyses (69%). The most 
popular software packages applied to perform this latter 
type of analysis were Cytoscape (41%) and MetaboAna-
lyst (55%). These high percentages confirm the importance 
of statistical and network-based tools in metabolomics 
research. Therefore, the full suite of common methods, as 
listed here, should be considered for implementation into 
Galaxy to address the needs of the community; good pro-
gress has already been achieved within the W4M Galaxy 
workflows (Giacomoni et al. 2015). However, poor experi-
mental design and the misuse of statistics (e.g. underpow-
ered experiments due to limited biological replication as 
well as the incorrect reporting of significance) can lead to 
the reporting of spurious and non-reproducible findings. 
For the community to benefit fully from the Galaxy imple-
mentation of these statistical methods, accompanying doc-
umentation and training should be developed and provided 
to ensure high quality metabolomics studies.
To complete the survey, one of the final steps in a typi-
cal metabolomics study was investigated (See SI2), that 
of metabolite annotation and/or identification. It is often 
regarded as the largest bottleneck in metabolomics research 
(Dunn et al. 2012), and there is an increasing requirement 
in metabolomics research to annotate tables of metabo-
lites according to their level of identification. To provide a 
definitive identification of a metabolite, at least two inde-
pendent orthogonal data that match an authentic compound 
measured under identical experimental conditions to the 
unknown compound are required (Sumner et  al. 2007). 
Putatively annotating and characterising compounds from 
full-scan MS1 can still be very informative, however, and 
is widely used in metabolomics. This is highlighted in the 
survey as 80%, of the respondents that answered, actively 
conducted metabolite annotation using full scan MS1 data. 
Of those, 70% used CAMERA to “annotate” full-scan MS1 
data (i.e. isotopes and adducts). Several other tools and 
software are used for MS1 annotation but each at a much 
lower percentage (<15%). The range of tools, databases 
and software packages used by the respondents to anno-
tate MSn data are more diverse and distributed; the top 
five included: Metlin 60%; MetFrag 45%; XCMS 44% and 
RMassBank 19%; NIST libraries and AMDIS 32% were 
used for GC–MS data annotation. For NMR Chenomx’s 
NMR suite (39%) and Bruker’s AMIX (39%) were the two 
main commercial software packages used to annotate, fol-
lowed by open source solutions such as the Birmingham 
Metabolite Library and associated data mining tools (22%), 
BATMAN (17%), and rNMR (9%). The diversity of exist-
ing Galaxy tools used to annotate MS and NMR-based data 
is limited in comparison to other software tools used by the 
community. Therefore, the widely used open-source metab-
olite annotation software should be wrapped for use in Gal-
axy to allow comprehensive metabolomics analysis from 
initial data processing through to metabolite annotation.
3  Conclusions from the survey
There is a need to develop tools as part of a user-friendly, 
automated data analysis workflow platform, such as Gal-
axy, which requires minimal bioinformatics skills to use, 
and that is well supported through community training (e.g. 
workshops, web-based tutorials and videos). The commu-
nity is ready to accept such workflows.
Data processing workflows are relatively well estab-
lished for MS and NMR-based metabolomics. For both, MS 
and NMR metabolomics, data processing tools are already 
available within Galaxy (Davidson et al. 2016; Giacomoni 
et al. 2015). Therefore, long term plans for implementation, 
growth, support and maintenance of those current Galaxy 
tools and workflows is recommended.
A large proportion of respondents use commercially-
licensed, Windows- and GUI-based software for data pro-
cessing and data analysis. This limits the adoption of such 
software within an open access and shareable workflow 
environment; where possible and necessary, open-source 
tools should be wrapped to provide an alternative via 
Galaxy. Additionally, the community should increase the 
efforts to involve commercial software partners and com-
panies as part of our community-based workflow develop-
ments to further improve integration and interoperability of 
current non-compatible software within standardised (Gal-
axy) workflows.
Univariate and multivariate statistical tools are exten-
sively used to analyse metabolomics data. All common 
statistical and network-based analysis tools, as indicated 
by respondents above and that are not already readily avail-
able in Galaxy, should be considered for implementation to 
fulfil the needs of the community, building on the progress 
already reported (Giacomoni et al. 2015).
The development of new analytical and computational 
methods for metabolite annotation is an active area of 
research in metabolomics. However, the number of tools 
to annotate and structurally identify metabolites within 
Galaxy is currently limited. Therefore, open-source 
metabolite annotation and identification software, which 
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is widely-used by the community, should be prioritised for 
inclusion within Galaxy workflows.
While the use of data repositories has increased (in 
terms of the percentage of respondents using these com-
modities over the last ca. 2 years), efforts should continue 
in community education about the value of these resources, 
further training in their use, and scripts embedded in Gal-
axy to facilitate automated deposition and integration into 
standard workflows.
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